PUT - SPRINTER OPEN END - PFIZER INC Stock

Certificat

DE000VX4TP33

Delayed Deutsche Boerse AG 14:03:39 2024-06-05 EDT
2.85 EUR +0.71% Intraday chart for PUT - SPRINTER OPEN END - PFIZER INC
Current month-3.06%
1 month-7.17%
Date Price Change
24-06-05 2.85 +0.71%
24-06-04 2.83 -0.70%
24-06-03 2.85 -3.06%
24-05-31 2.94 -1.34%
24-05-30 2.98 -0.67%

Delayed Quote Deutsche Boerse AG

Last update June 05, 2024 at 02:03 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VX4TP3
ISINDE000VX4TP33
Date issued 2021-12-16
Strike 60.27 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.31
Lowest since issue 0.29
Spread 0.02
Spread %0.70%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.55 USD
Average target price
31.92 USD
Spread / Average Target
+8.00%
Consensus